Takeda Pharmaceutical (TAK) Total Non-Current Liabilities (2017 - 2026)
Takeda Pharmaceutical (TAK) reported Total Non-Current Liabilities of $33.5 billion for the quarter ended Jun 30, 2026, down 2.4% from $34.34 billion a year earlier but up 0.1% from the prior quarter.
Powered by 
Analysis
Takeda Pharmaceutical (TAK) Total Non-Current Liabilities (2017 - 2026) Analysis & Trends
As of Mar 31, 2026, Takeda Pharmaceutical posted Total Non-Current Liabilities of $34.87 billion, up 10.5% from the prior year.
- Total Non-Current Liabilities has a five-year compound annual growth rate of -9.1% (years ended Mar 2021 to Mar 2026).
- By year, Total Non-Current Liabilities came in at $31.55 billion in the year ended Mar 31, 2025 (-17.6%), $38.29 billion in the year ended Mar 31, 2024 (+1.0%), $37.91 billion in the year ended Mar 31, 2023 (-20.4%) and $47.64 billion in the year ended Mar 31, 2022 (-15.3%).
- Five-year quarterly Total Non-Current Liabilities spans a low of $31.5 billion in the quarter ended Mar 31, 2025 and a high of $46.03 billion in the quarter ended Mar 31, 2022.
- Year over year, Total Non-Current Liabilities gained in two of the last eight quarters, with an average decline of 4.1%.
- The high point for year-over-year Total Non-Current Liabilities in five years was the quarter ended Mar 31, 2026 (growth of 6.2%); the low point was the quarter ended Mar 31, 2022 (a decline of 18.3%).
- Per Business Quant data, the three quarters before the quarter ended Jun 30, 2026 came in at $33.47 billion (quarter ended Mar 31, 2026), $33.49 billion (quarter ended Dec 31, 2025) and $35.28 billion (quarter ended Sep 30, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 105.99 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 106.45 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 80.25 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 48.34 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | -967.00 Mn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 81.11 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 36.04 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 100.86 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 5.92 Bn |
| 10 | Takeda Pharmaceutical | 2.68 Bn | -23.83 Bn | 5.10 Bn | 33.50 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 33.50 Bn |
| Mar 31, 2026 | 33.47 Bn |
| Dec 31, 2025 | 33.49 Bn |
| Sep 30, 2025 | 35.28 Bn |
| Jun 30, 2025 | 34.34 Bn |
| Mar 31, 2025 | 31.50 Bn |
| Dec 31, 2024 | 36.77 Bn |
| Sep 30, 2024 | 35.29 Bn |
| Jun 30, 2024 | 38.31 Bn |
| Mar 31, 2024 | 37.26 Bn |
| Dec 31, 2023 | 35.17 Bn |
| Sep 30, 2023 | 37.62 Bn |
| Jun 30, 2023 | 39.18 Bn |
| Mar 31, 2023 | 38.72 Bn |
| Dec 31, 2022 | 36.04 Bn |
| Sep 30, 2022 | 39.70 Bn |
| Jun 30, 2022 | 43.16 Bn |
| Mar 31, 2022 | 46.03 Bn |
| Jun 30, 2021 | 52.18 Bn |
| Mar 31, 2021 | 56.33 Bn |
API Access
Takeda Pharmaceutical Total Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=TAK&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-non-current-liabilities", "ticker": "TAK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=TAK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();